Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.560
-0.080 (-4.88%)
At close: Feb 21, 2025, 4:00 PM
1.592
+0.032 (2.03%)
After-hours: Feb 21, 2025, 6:30 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $23.15 million as of February 21, 2025. Its market cap has increased by 73.78% in one year.
Market Cap
23.15M
Enterprise Value
1.97M
1-Year Change
73.78%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $23.15M, a decrease of -86.58%. That is a compound annual growth rate of -39.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 23.15M | -9.83% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |